Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer.

Sci Rep · 2023 · PMC10654731 · PMID 37973935

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

showed a trendP = 0.061so close (0.05 < p ≤ 0.1)

Claudin 18.2-positive tumors showed a trend toward a lower proportion of lymph node metastasis (55.4% vs. 66.7%, P = 0.061).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.